TEVA PHARMACEUTICAL INDUSTRIES LIMITED Short-Term Debt
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Short-Term Debt of $4.50 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2026-07-29
- 2026-06-30: Debt, Current $4.50B.
- 2026-03-31: Debt, Current $2.61B.
- 2025-12-31: Debt, Current $1.82B.
- 2025-09-30: Debt, Current $24.00M.
| Period end | Debt, Current | Debt, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.50B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $2.61B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $1.82B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $24.00M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $464.00M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $421.00M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $1.78B 10-K · filed 2026-02-03 | |
| 2024-09-30 | $2.58B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $2.09B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $3.06B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.67B 10-K · filed 2025-02-05 | |
| 2023-09-30 | $1.48B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.98B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $1.02B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.11B 10-K · filed 2024-02-12 | |
| 2022-09-30 | $2.77B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $1.72B 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $2.08B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $1.43B 10-K · filed 2023-02-10 | |
| 2021-09-30 | $2.71B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $3.53B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $2.70B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $3.19B 10-K · filed 2022-02-09 | |
| 2020-09-30 | $2.11B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.65B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.63B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.35B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $3.13B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.77B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $2.79B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $2.22B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $2.67B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $1.27B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.30B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $3.65B 10-K · filed 2019-02-19 | |
| 2017-09-30 | $2.73B 6-K · filed 2017-11-02 | |
| 2017-06-30 | $1.25B 6-K · filed 2017-08-03 | |
| 2017-03-31 | $1.94B 6-K · filed 2017-05-11 | |
| 2016-12-31 | $3.28B 10-K · filed 2018-02-12 | |
| 2016-09-30 | $3.68B 6-K · filed 2016-11-15 | |
| 2016-06-30 | $2.88B 6-K · filed 2016-08-04 | |
| 2016-03-31 | $1.58B 6-K · filed 2016-05-09 | |
| 2015-12-31 | $1.58B 20-F · filed 2017-02-15 | |
| 2015-09-30 | $2.15B 6-K · filed 2015-10-29 | |
| 2015-06-30 | $3.02B 6-K · filed 2015-07-30 | |
| 2015-03-31 | $1.63B 6-K · filed 2015-04-30 | |
| 2014-12-31 | $1.76B 20-F · filed 2016-02-11 | |
| 2014-09-30 | $1.83B 6-K · filed 2014-10-30 | |
| 2014-06-30 | $2.05B 6-K · filed 2014-07-31 | |
| 2014-03-31 | $1.55B 6-K · filed 2014-05-02 | |
| 2013-12-31 | $1.80B 20-F · filed 2015-02-09 | |
| 2013-09-30 | $2.54B 6-K · filed 2013-10-31 | |
| 2013-06-30 | $2.53B 6-K · filed 2013-08-01 | |
| 2013-03-31 | $2.72B 6-K · filed 2013-05-02 | |
| 2012-12-31 | $3.01B 20-F · filed 2014-02-10 | |
| 2012-09-30 | $571.00M 6-K · filed 2012-11-01 | |
| 2012-06-30 | $889.00M 6-K · filed 2012-08-02 | |
| 2012-03-31 | $3.83B 6-K · filed 2012-05-09 | |
| 2011-12-31 | $4.28B 20-F · filed 2013-02-12 | $3.75B 20-F · filed 2012-02-17 |
| 2011-09-30 | $3.28B 6-K · filed 2011-11-02 | |
| 2011-06-30 | $1.93B 6-K · filed 2011-07-28 | |
| 2011-03-31 | $1.34B 6-K · filed 2011-05-11 | |
| 2010-12-31 | $1.43B 20-F · filed 2012-02-17 | |
| 2010-09-30 | $1.08B 6-K · filed 2010-11-02 | |
| 2010-06-30 | $1.95B 6-K · filed 2010-07-27 | |
| 2010-03-31 | $1.97B 6-K · filed 2010-05-04 | |
| 2009-12-31 | $659.00M 20-F · filed 2011-02-15 | $1.30B 20-F · filed 2010-02-22 |
| 2009-09-30 | $1.48B 6-K · filed 2009-11-03 | |
| 2009-06-30 | $2.03B 6-K · filed 2009-07-29 | |
| 2009-03-31 | $3.36B 6-K · filed 2009-05-07 | |
| 2008-12-31 | $2.91B 20-F · filed 2010-02-22 |